Search
for
Sort by
Research 30 of 1000+
- Drug Therapy in Polycystic Ovarian Syndrome
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Avaliação do impacto da redução significativa de peso pela dieta cetogênica de muito baixa caloria nos parâmetros metabólicos, inflamatórios, hormonais e seminais de homens obesos
- The Role of Non-Aromatizable Testosterone Metabolite in Metabolic Pathways
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Physiological analysis of Iraqi male patients with hair loss: A cross-sectional study
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- Potential adverse effects of long-term testosterone therapy
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- Body Composition and Characterization of Skinfold Thicknesses from Polycystic Ovary Syndrome Phenotypes. A Preliminar Case-Control Study
- Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
- Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Virilizing ovarian steroid cell tumor in a 40 year old South Indian female: a case report
- Parameters of obesity in polycystic ovary syndrome
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Essential Fatty Acid Deficiency (EFAD) in a Patient with Vascular Ehlers Danlos Syndrome (EDS-4) (P12-053-19)
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- P-50 WE KNOW YOU ARE THERE: MISSING MASS
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Acute chylous peritonitis due to idiopathic pancreatitis mimicking acute appendicitis
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence